The rapid growth in GLP-1 use could reshape the U.S. agricultural landscape
This study projects that the widespread adoption of GLP-1 medications in North America will significantly reduce food demand by 2030, leading to substantial declines in agricultural land rents and reshaping the U.S. food system primarily through adjustments in trade, imports, and exports rather than domestic production alone.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Imagine a world where the way we eat changes not because of a new diet trend or a shift in the weather, but because of a medical breakthrough. For decades, scientists have understood that certain medicines can help people lose weight by making them feel full faster and reducing their overall hunger. These drugs, known as GLP-1 receptor agonists, were originally designed to help people manage diabetes, but they have recently become a powerful tool for treating obesity. As more people gain access to these treatments, a quiet revolution is taking place in how much food we consume. This shift is not just a matter of personal health; it ripples outward, touching the vast networks that grow, transport, and sell the food we rely on. The question researchers are now asking is simple but profound: if millions of people suddenly eat less, what happens to the farms, the trade routes, and the land that feeds them?
A team of economists and agricultural scientists set out to answer this by building a detailed computer simulation of the food systems in the United States, Canada, and Mexico. They wanted to see how the spread of these weight-loss medicines would reshape the agricultural landscape by the year 2030. To do this, they did not just guess; they combined two very different types of information. First, they used statistical models to predict how many people would start taking the medicine, how many would stop, and how many would start again, based on current rules about who can get the drugs and how easy it is to afford them. Second, they looked at clinical data showing exactly how much less food a person eats while on the treatment. By linking these two pieces, they created a realistic picture of how much total food demand would drop across the region. They then fed this information into a massive economic model that simulates how prices, production, and trade adjust when the amount of food people want to buy changes.
The results reveal that the impact of these medicines will be significant, but the way the system absorbs the change is more complex than simply growing less food. The researchers found that by 2030, if the current rules for accessing these drugs remain in place, about 15.6 percent of U.S. adults could be actively using them. If access were expanded to include more people who are overweight, that number could jump to 28.4 percent. This shift in behavior would reduce the total demand for food in the United States by between 3.9 and 6.4 percent under current conditions, and by as much as 7.1 to 11.6 percent if access were broadened. However, the farmers and producers do not simply cut their output by that exact same amount. Instead, the market finds a balance through a mix of changes. Domestic production does fall, particularly for sugar, meat, dairy, and processed foods, but it is not the only thing that changes. Imports drop even more sharply, and exports actually increase. In other words, the food that is no longer eaten by American consumers is not just left in the fields; it is redirected to other markets, and the country buys less from abroad.
The study also highlights that the biggest driver of these changes is who gets to take the medicine, not just where the medicine is used. When the researchers simulated a scenario where Canada and Mexico also saw a rise in drug use, the total amount of food produced in the United States did not change much more than it did with U.S. use alone. Instead, the main effect was a reshuffling of trade. American farmers sold slightly less to their neighbors in Canada and Mexico, while the flow of food between those countries and the rest of the world adjusted. This suggests that the rules governing who can buy the drug in the United States are the primary factor determining how much the American farm sector shrinks, while the spread of the drug to other countries mostly changes the direction of trade rather than the total volume of production.
Perhaps the most striking finding concerns who bears the cost of this change. The researchers looked at how the economic shock affected different parts of the farming business, such as the money paid to workers, the returns on machinery, and the value of the land itself. They found that wages and returns on capital changed very little. The real impact fell heavily on the land. The value of renting agricultural land, known as land rents, was projected to fall by about 2.3 to 2.4 percent under current conditions, and by 4.1 to 4.2 percent if access to the drugs were expanded. This means that the owners of the land would feel the financial pinch much more than the workers or the owners of the equipment. The study also looked at the environmental side, noting that while emissions from food production would drop because less is being grown, this does not necessarily mean the total environmental impact of the economy goes down. As the economy shifts to produce less food and more of other things, emissions in non-food sectors could rise, offsetting some of the gains.
Ultimately, this research shows that a medical innovation can become a powerful force in the agricultural world, reshaping markets in ways that are not immediately obvious. It demonstrates that when a large number of people change their eating habits, the economy does not just shrink in a straight line; it rearranges itself through trade, prices, and the value of resources. The study suggests that agricultural planners and policymakers cannot look at food demand in isolation anymore. They must consider how health policies, insurance coverage, and drug availability will alter the very foundation of what and how much we grow. By 2030, the landscape of American agriculture may look different not because of a drought or a new technology, but because millions of people are simply eating less.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.